Jin Medical EBITDA Margin 2023-2025 | ZJYL
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Jin Medical (ZJYL) over the last 10 years. The current EBITDA margin for Jin Medical as of March 31, 2025 is .
| Jin Medical EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.041B | $0.024B |
| Jin Medical International Ltd. through its Chinese operating entities, designs and manufactures wheelchairs and living aids products for people with disabilities, the elderly and people recovering from injuries. Jin Medical International Ltd. is headquartered in Changzhou City, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.907B | 25.23 |
| EssilorLuxottica (ESLOY) | France | $167.835B | 0.00 |
| Boston Scientific (BSX) | United States | $149.593B | 34.21 |
| Stryker (SYK) | United States | $135.768B | 26.96 |
| Medtronic (MDT) | Ireland | $118.854B | 16.76 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.878B | 0.00 |
| Agilent Technologies (A) | United States | $41.493B | 26.85 |
| ResMed (RMD) | United States | $36.500B | 25.26 |
| GE HealthCare Technologies (GEHC) | United States | $33.472B | 16.01 |
| Koninklijke Philips (PHG) | Netherlands | $27.202B | 17.77 |
| Terumo (TRUMY) | Japan | $24.340B | 28.84 |
| Insulet (PODD) | United States | $22.536B | 69.94 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.585B | 10.97 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.234B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.124B | 7.37 |
| Bio-Rad Laboratories (BIO) | United States | $8.292B | 29.81 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| ICU Medical (ICUI) | United States | $3.437B | 21.82 |
| Lantheus Holdings (LNTH) | United States | $3.361B | 10.24 |
| Haemonetics (HAE) | United States | $3.299B | 14.68 |
| Envista Holdings (NVST) | United States | $3.297B | 18.92 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.907B | 13.26 |
| LeMaitre Vascular (LMAT) | United States | $1.992B | 40.09 |
| Curaleaf Holdings (CURLF) | Canada | $1.977B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.961B | 4.91 |
| Phibro Animal Health (PAHC) | United States | $1.858B | 18.56 |
| Green Thumb Industries (GTBIF) | United States | $1.612B | 70.64 |
| AtriCure (ATRC) | United States | $1.590B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.471B | 0.00 |
| Neogen (NEOG) | United States | $1.382B | 26.50 |
| Kestra Medical Technologies (KMTS) | United States | $1.359B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.340B | 8.62 |
| AdaptHealth (AHCO) | United States | $1.272B | 18.43 |
| BioLife Solutions (BLFS) | United States | $1.266B | 375.57 |
| InMode (INMD) | Israel | $0.923B | 10.43 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.792B | 0.00 |
| Valneva SE (VALN) | France | $0.764B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.500B | 17.23 |
| SNDL (SNDL) | Canada | $0.491B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.474B | 0.00 |
| Evolus (EOLS) | United States | $0.457B | 0.00 |
| Omeros (OMER) | United States | $0.449B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.438B | 0.00 |
| CeriBell (CBLL) | United States | $0.437B | 0.00 |
| Surmodics (SRDX) | United States | $0.391B | 0.00 |
| Cerus (CERS) | United States | $0.307B | 0.00 |
| Brainsway (BWAY) | Israel | $0.306B | 62.00 |
| Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.294B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.263B | 155.67 |
| High Tide (HITI) | Canada | $0.262B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.254B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.251B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.249B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.243B | 19.36 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Owens & Minor (OMI) | United States | $0.228B | 2.29 |
| Organigram Global (OGI) | Canada | $0.222B | 0.00 |
| Exagen (XGN) | United States | $0.214B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.210B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.199B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 16.18 |
| FitLife Brands (FTLF) | United States | $0.174B | 21.46 |
| OraSure Technologies (OSUR) | United States | $0.167B | 0.00 |
| Apyx Medical (APYX) | United States | $0.157B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.140B | 0.00 |
| Biote (BTMD) | United States | $0.122B | 4.92 |
| Sharps Technology (STSS) | United States | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.106B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 13.49 |
| MacroGenics (MGNX) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.062B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.00 |
| Nephros (NEPH) | United States | $0.046B | 33.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Zynex (ZYXI) | United States | $0.036B | 0.00 |
| Bonk (BNKK) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.65 |
| Modular Medical (MODD) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |